CORAL GABLES, FL / ACCESSWIRE / December 18, 2018 / Marijuana stocks have seen a lot of excitement this year. As 2019 gets closer, Premier Health Group (OTC:PHGRF) (CSE:PHGI), Aurora Cannabis (ACB), Cara Therapeutics (CARA) and Canopy Growth (CGC) are 4 marijuana stocks to pay attention to heading into the New Year.
This month Premier Health Group (OTC:PHGRF) (CSE:PHGI) hit highs of 0.80 to mark a move of more than 30% within the last 30 days. The company has been focused on growth in the healthcare and cannabis industries. This week The Company announced that it has signed a binding LOI to acquire all of the outstanding securities of Cloud Practice Inc. Products include Juno EMR, a cloud-based EMR solution; ClinicAid, a medical billing software; and MyHealthAccess, an online patient portal.
Juno EMR system is currently used by 287 clinics, over 3,000 licensed practitioners, 1,500 staff and 2,870,000 registered patients. Furthermore, ClinicAid processes upwards of $30,000,000 in payments to over 3000 health providers on a monthly basis.
According to the company's announcement, Cloud Practice already has a tremendous standalone and growing business serving thousands of clinicians and millions of patients. The collective ecosystem of over 3,000,000 patients creates an opportunity to become a key player in the telehealth space in Canada.
Aurora Cannabis (ACB) announced earlier this month that it has entered into an agreement to invest $10 million by way of brokered private placement in High Tide Inc., a privately held, Alberta -based, retail-focused cannabis and lifestyle accessories company.
The company has seen its share price increase over the last 2 weeks. During premarket trading on Tuesday morning, Aurora shares traded as high as $5.56. This is 16% higher than where it opened on December 6.
Cara Therapeutics (CARA) found itself in headlines on Tuesday. The company was mentioned on the Monday night edition of Jim Cramer's Mad Money. The CNBC host said, ''I like it. We had them on. I thought they did a lot of good. I told a bunch of people that they ought to get in their trials. Of course, it is not exactly what people want in this market, but one day, this market will change its coloration and they'll come back to buying Cara.''
According to its profile on Yahoo Finance, Cara Therapeutics, Inc. is a clinical-stage biopharmaceutical company and focuses on developing and commercializing chemical entities designed to alleviate pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and immune cells.
Canopy Growth (CGC) saw premarket trading take its shares higher on Tuesday morning. Canopy is one of the largest cannabis companies in the world and saw highs of $29.60 before the opening bell.
Canopy announced earlier this month that it has entered into a multi-year extraction agreement with Valens GroWorks Corp., a licensed, vertically integrated provider of cannabis products and services focused on various proprietary extraction methodologies, distillation, cannabinoid isolation, and purification.
MarijuanaStocks.com is the leading web destination for all things cannabis. Investors can find marijuana-related financial, medical, legal, and social news anytime day or night. Writers are invited to submit cannabis related articles for publication.
Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. MAPH Enterprises LLC which owns www.MarijuanaStocks.com is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release.
MAPH Enterprises LLC, which owns www.MarijuanaStocks.com, may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice. MAPH Enterprises LLC, which owns www.MarijuanaStocks.com, may be compensated for its services in the form of cash-based compensation or equity securities in the companies it writes about, or a combination of the two. Pursuant to an agreement between an affiliate of MAPH Enterprises, LLC (owners of MarijuanaStocks.com), MIDAM VENTURES, LLC and Premier Health Group Inc., Midam was hired for a period from 10/1/2018 – 4/1/2019 to publicly disseminate information about Premier Health Group Inc. including on the Website and other media including Facebook and Twitter. Midam was paid $100,000 (CASH) for & were paid ''500,000'' shares of restricted common shares. We own zero shares of Premier Health Group Inc., which we purchased in the open market. Once the (6) Six-month restriction is complete on 4/1/2019 Midam plans to sell the ''500,000'' shares of Premier Health Group Inc. that Midam holds currently in restricted form during the time the Website and/or Facebook and Twitter Information recommends that investors or visitors to the website purchase without further notice to you. We may buy or sell additional shares of Premier Health Group Inc. in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information. As of December 11, 2018 a member of MAPH holds 550 Aurora Call Options and 35,000 shares of Aurora purchased in the open market and may be sold at any time. Our full disclaimer will update at such time. Click here for our full disclaimer.